ReviewMediterranean journal of hematology and infectious diseases2014

Second-Generation Tyrosine Kinase Inhibitors (Tki) as Salvage Therapy for Resistant or Intolerant Patients to Prior TKIs.

Massimo Breccia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.